Therapeutic hypothermia after non‑traumatic cardiac arrest for 12 hours: Hospital Karlovy Vary from 2006 to 2009
Authors:
R. Sýkora; R. Janda
Authors place of work:
Anesteziologicko‑resuscitační oddělení nemocnice v Karlových Varech, Karlovarská krajská nemocnice, a. s., přednosta prim. MU Dr. Roman Brázdil
Published in the journal:
Vnitř Lék 2011; 57(1): 72-77
Category:
Original Contributions
Summary
Introduction and aims:
Therapeutic hypothermia is a standard part of post-resuscitation care. Here we present cohort patients after non-traumatic cardiac arrest and their neurological outcomes who underwent 12 hours of therapeutic hypothermia. Moreover, we focused on examining the results of particular subgroup of patients with initial ventricular fibrillation (VF) with acute myocardial infarction with ST-elevation (STEMI) who underwent coronary intervention (PCI).
Methods:
We evaluated retrospectively the patients with non-traumatic out- of- and in-hospital cardiac arrest (IHCA, OHCA), admitted to our intensive care unit (ICU) in 2006– 2009. Therapeutic hypothermia was induced in all patients with persistent coma after restoration of spontaneous circulation (ROSC). We maintained the target temperature (32– 34 °C) for 12 hours. Then, passive rewarming followed. Intravascular cooling device was not used. A good neurological outcome was considered to be cerebral performance category (CPC) 1 or 2 at hospital discharge.
Results:
Total number of patients was 88 (OHCA n = 63; IHCA n = 25), average age 58 (± 16) years, average APACHE II was 29 (± 6). Men were in 65%. Target temperature was achieved and maintained in 76% of patients. ICU mortality was 32%, hospital mortality 53%. Initial ECG rhytm was VF in 59%, asystoly in 32% and pulsless electrical activity in 9%. Coronary angiography was performed in 57% and PCI in 42% patients. We did not observe severe arrhythmias, minor gastrointestinal bleeding occured in 2%. The infectious complications were recorded: early pneumonia in 7%, tracheobronchitis in 10% and bacteraemia in 1% patients. In the group of 23 patients with VF/ STEMI/ PCI target temperature was achieved and maintained in 91%, ICU and hospital survival rates were 87% and 78%. CPC 1 and 2 was observed in 83% among survivors (n = 15).
Conclusions:
We achieved similar results in patients after non-traumatic cardiac arrest who underwent a protocol with 12 hours of therapeutic hypothermia as in studies reporting 24 hours of hypothermia, particularly in patients with VF/ STEMI/ PCI. Twelve hours of therapeutic hypothermia was associated with a low incidence of infectious complications.
Key words:
therapeutic hypothermia – cardiac arrest – protocol
Zdroje
1. Nolan JP, Morley PT, Vanden Hoek TL et al. Therapeutic hypothermia after cardiac arrest. An advisory statement by the Advancement Life support Task Force of the International Liaison committee on Resuscitation. Resuscitation 2003; 57: 231– 235.
2. American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005; 112: IV1– IV203.
3. Bělohlávek J, Šmíd O. Neuroprotekce po srdeční zástavě a časná poresuscitační péče – editorial. Vnitř Lék 2009; 55: 1011– 1013.
4. Bernard SA, Gray TW, Buist MD et al. Treatment of comatose survivors of out- of- hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346: 557– 563.
5. The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346: 549– 556.
6. Škulec R, Truhlář A, Ošťádal P et al. Současné ochlazovací metody pro indukci mírné hypotermie po srdeční zástavě. Vnitř Lék 2009; 55: 1060– 1069.
7. Skulec R, Truhlar A, Knor J et al. Broad implementation of therapeutic hypothermia after cardiac arrest- Mission possible. Resuscitation 2010; 81: 779– 780.
8. Target Temperature Management After Cardiac Arrest. (TTM trial). NCT01020916. http:/ / clinicaltrials.gov. http:/ / clinicaltrials.gov. 2010.
9. Castren M, Silfvast T, Rubertsson S et al. Scandinavian clinical practice guidelines for therapeutic hypothermia and post-resuscitation care after cardiac arrest. Acta Anaesthesiol Scand 2009; 53: 280– 288.
10. Clinical and Economical Interest of Endovascular Cooling in the Management of Cardiac Arrest. (ICEREA Study). NCT00392639. http:/ / clinicaltrials.gov. 2009.
11. Škulec R, Kovárnik T, Bělohlávek J et al. Nadměrné ochlazení během mírné hypotermie po srdeční zástavě – fenomén zasluhující pozornost. Vnitř Lék 2008; 54: 609– 614.
12. Hoedemaekers CW, Ezzahti M, Gerritsen A et al. Comparison of cooling methods to induce and maintain normo- and hypothermia in intensive care unit patients: a prospective intervention study. Crit Care 2007; 11: R91.
13. Sagalyn E, Band RA, Gaieski DF et al. Therapeutic hypothermia after cardiac arrest in clinical practice: review and compilation of recent experiences. Crit Care Med 2009; 37: S223– S226.
14. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med 2009; 37: S186– S202.
15. Polderman KH, Herold I. Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods. Crit Care Med 2009; 37: 1101– 1120.
16. Simosa HF, Petersen DJ, Agarwal SK et al. Increased risk of deep venous thrombosis with endovascular cooling in patients with traumatic head injury. Am Surg 2007; 73:461– 464.
17. Kuisma M, Boyd J, Voipio V et al. Comparison of 30 and the 100% inspired oxygen concentrations during early post-resuscitation period: a randomised controlled pilot study. Resuscitation 2006; 69: 199– 206.
18. Ronning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi- randomized controlled trial. Stroke 1999; 30: 2033– 2037.
19. Luecke T, Pelosi P. Clinical review: Positive end-expiratory pressure and cardiac output. Crit Care 2005; 9: 607– 621.
20. Finfer S, Chittock DR, Su SY et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283– 1297.
21. Jansen TC, van BJ, Schoonderbeek J et al. Early Lactate- Guided Therapy in ICU Patients: A Multicenter, Open- Label, Randomized, Controlled Trial. Am J Respir Crit Care Med 2010; 182: 752– 761.
22. Wijdicks EF, Hijdra A, Young GB et al. Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006; 67: 203– 210.
23. Young GB. Clinical practice. Neurologic prognosis after cardiac arrest. N Engl J Med 2009; 361: 605– 611.
24. Doporučení představenstva ČLK č. 1/ 2010 k postupu při rozhodování o změně léčby intenzivní na léčbu paliativní u pacientů v terminálním stavu, kteří nejsou schopni vyjádřit svou vůli.
25. Safar P. Resuscitation after Brain Ischemia. In: Grenvik A, Safar P. Brain Failure and Resuscitation. New York: Churchill Livingstone 1981: 155– 184.
26. Hovdenes J, Laake JH, Aaberge L et al. Therapeutic hypothermia after out- of- hospital cardiac arrest: experiences with patients treated with percutaneous coronary intervention and cardiogenic shock. Acta Anaesthesiol Scand 2007; 51: 137– 142.
27. Knafelj R, Radsel P, Ploj T et al. Primary percutaneous coronary intervention and mild induced hypothermia in comatose survivors of ventricular fibrillation with ST-elevation acute myocardial infarction. Resuscitation 2007; 74: 227– 234.
28. Wolfrum S, Pierau C, Radke PW et al. Mild therapeutic hypothermia in patients after out- of- hospital cardiac arrest due to acute ST-segment elevation myocardial infarction undergoing immediate percutaneous coronary intervention. Crit Care Med 2008; 36: 1780– 1786.
Štítky
Diabetology Endocrinology Internal medicineČlánok vyšiel v časopise
Internal Medicine
2011 Číslo 1
Najčítanejšie v tomto čísle
- A delay in the HELLP syndrome diagnosis
- Diagnosis and treatment of acute pulmonary embolism in 2010
- Obesity, body mass index, waist circumference and mortality
- A case of a flapping infected thrombus in the internal jugular vein, septic pneumonias and heparin‑induced thrombocytopaenia